Sirius Medical announces FDA clearance of Sirius Pintuition for Breast Cancer Surgery
Sirius Medical announces FDA clearance of Sirius Pintuition for Breast Cancer Surgery. This clearance paves the way for Sirius to launch its Pintuition System in the United States. Read the full press release here: https://hubs.li/H0JT7tJ0
“We are extremely pleased to have received this clearance and to have the opportunity to support U.S. clinicians and patients with our products,” says Hubert Martens, CEO and co-founder of Sirius.
Sirius Pintuition offers a non-radioactive, wire-free, pinpoint approach to localize non-palpable breast tumors.
Source: Sirius Medical